ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03406780
Recruitment Status : Recruiting
First Posted : January 23, 2018
Last Update Posted : November 2, 2018
Sponsor:
Information provided by (Responsible Party):
Capricor Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : April 2020